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The fluorescent dye rhodamine 123 (R123) decreases the intracellular ATP levels and also inhibits the degradation of 
short-lived proteins in isolated hepatocytes. This inhibition affects lysosomal and, lo some extent, non-lysosomal mecha- 
nisms. The degradation of short-lived proteins decreases more when ATP levels are less than 40% of those in control 
cells, in contrast to the reported linear correlation between ATP levels and degradation of long-lived proteins. R123 pro- 
vides a powerful probe for clarifying the proteolytic mechanisms involved in degradation of short-lived proteins and the 
ATP requirements in protein degradation. Indeed, as illustrated, the results suggest different mechanisms for the degrada- 
tion of short- and long-lived proteins. Moreover, they provide a warning for the clinical use of this reagent. 
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1. INTRODUCTION 
Intracellular proteins have been classified into 
two main groups [l-3]: (i) long-lived proteins, 
with relatively slow turnover rates, which con- 
stitute the bulk of cellular proteins; and (ii) short- 
lived proteins, with an exceptionally high turnover 
rate, which in liver represent less than 1% of the 
protein content, but 15-20% of protein synthesis 
[4,5]. The degradative mechanisms of short-lived 
proteins remain to be clarified, mainly due to the 
lack of specific methods for modifying their 
degradation rate [l-3]. 
It has been hypothesized that part of the short- 
lived proteins correspond to the cleavage and pro- 
teolysis of signal sequences from mitochondrial 
and other proteins [6]. Since the fluorescent dye 
rhodamine 123 (R123) in isolated hepatocytes in- 
hibits the transport and processing of mitochon- 
drial protein precursors [7], it seemed useful for 
the study of degradation of short-lived proteins. 
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We show here that R123 strongly inhibits the 
degradation of short-lived proteins in isolated 
hepatocytes. 
2. MATERIALS AND METHODS 
2.1. Cells and culture conditions 
Hepatocytes were prepared from livers of male Wistar rats 
(200-300 g body wt) by the collagenase perfusion method [8] 
and incubated in a rapidly shaking water bath at 37°C under an 
atmosphere of 10% CO#O% air, in Hanks’ medium sup- 
plemented with penicillin (30 gg/ml), streptomycin sulphate 
(250 pg/ml), a mixture of 20 amino acids (at concentrations ap- 
prox. 1.5-times their physiological levels) and 20 mM Hepes 
(pH 7.3) [9]. Cell viability, measured by the trypan blue exclu- 
sion test, was greater than 90% at the end of incubations. 
2.2. Protein degradation 
Protein degradation was measured in isolated hepatocytes 
(10’ cells/ml) based on the release of [%]valine from pre- 
labelled proteins [lo]. Short-lived proteins were labelled by in- 
cubation of 25 ml cell suspension (10’ cells/ml) in IOO-ml con- 
ical flasks for 1 h [2], with 250&i [‘4C]valine (280 Ci/mol, 
50 mCi/l). The bulk of the non-incorporated [‘4C]valine was 
removed by washing cells twice in fresh medium containing 
2 mM valine (‘cold’ medium). The cells were then incubated for 
10 min in 500 ml conical flasks with 50 ml cold medium and, 
finally, washed twice. 
Experiments were carried out in cold medium with the addi- 
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tions indicated in the figures. Portions of the cell suspension 
(1 ml) were taken at different times during the chase period, 
and assayed for trichloroacetic acid-soluble and -precipitable 
radioactivity by liquid scintillation counting [2,10]. The net 
release of trichloroacetic acid-soluble radioactivity dining the 
incubation period was expressed as % of the initial radioactivity 
incorporated into the protein [2,10]. 
2.3. Measurements of ATP and protein 
ATP was measured by the firefly luciferin-luciferase reaction 
[ll]. l-ml aliquots of the suspension of hepatocytes (10’ 
cells/ml) were centrifuged at 600 x g. The cell pellets were 
mixed with 1 ml of 1 M HC104. After 30 min at 0-4’C they 
were sonicated (200 W, 1 min, at 0-4°C) and then centrifuged 
at 10000 x g for 10 min. Supernatants were neutralized. The 
assay was linear from about 6 x lo-” to IO-’ M ATP. Biuret 
[12] and Lowry [13] methods were used for protein 
measurements. 
2.4. Chemicals 
RI23 (Eastman-Kodak, Rochester, NY) was dissolved in 
ethanol (20 mg/ml). [t4C]Valine was purchased from Amer- 
sham (England). Leupeptin was obtained from Sigma (St. 
Louis, MO) and ammonium chloride from Merck (Darmstadt, 
FRG). The ATP-bioluminescence test was from Boehringer 
(Mannheim). The rest of the chemicals were of the highest puri- 
ty available. 
3. RESULTS AND DISCUSSION 
R123 produced a dose-dependent decrease in 
degradation rate of short-lived proteins (fig. l), 
with the maximum inhibitory effect (-65%) at 
100 pug/ml (higher concentrations reduced cell 
viability below 85% and were therefore not used). 
Similar effects were also obtained when R123 was 
added during the ‘pulse’ period (not shown). 
Moreover, under these conditions, there was 
50-60% inhibition of protein synthesis. In 
hepatocytes, mitochondrial proteins represent 
20% of the total; more than 90% of these proteins 
are synthesized in the cytosol as precursors [14]. 
However, the observed inhibition appears greater 
than that expected from only an impairment of 
transport and processing of mitochondrial protein 
precursors. Therefore, we next explored the 
mechanism(s) by which R123 affects the degrada- 
tion of short-lived proteins. 
R123 directly and selectively stains mitochondria 
in fibroblasts [15] and hepatocytes [16]. It has been 
shown that in isolated mitochondria R123 inhibits 
oxidative phosphorylation [17] and that its uptake 
depends on the mitochondrial membrane potential 
[18]. Since ATP is often required for protein 
degradation [3,19], the inhibitory effect of RI23 
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could be due to a decrease in intracellular levels of 
ATP. As shown in fig.2, at all R123 concentrations 
used, there was a sharp and rapid decrease in ATP 
content. When the rates of degradation of short- 
lived proteins in the presence of different concen- 
trations of R123 were plotted vs intracellular ATP 
levels (fig.3), no linear correlation between ATP 
content and degradation rate of short-lived pro- 
teins was found. The initial rapid fall in ATP 
(down to about 35% of control values) produced 
by the lowest concentration of R123 used de- 
creased proteolysis of short-lived proteins by only 
20% (fig.3), but as the level of ATP decreased to 
about 20% of control values, the proteolysis was 
reduced much more (-65%). These results con- 
trast with the linear relationship found in isolated 
hepatocytes between the inhibition in degradation 
rate of long-lived proteins by autophagic processes 
and decrease in ATP content 1201. They are, 
however, similar to those reported in growing 
fibroblasts with both short- and long-lived proteins 
[21]. Therefore, the findings described here sup- 
port the existence of different mechanisms for the 
degradation of short- and long-lived proteins in 
hepatocytes. 
In growing fibroblasts, short- and long-lived 
proteins appear to be degraded via non-lysosomal 
pathways [19,21]. In hepatocytes most degradation 
of long-lived proteins is lysosomal [22-241, 
whereas only about one-half of the short-lived pro- 
time (mid 
Fig.1. Inhibition by R123 of the degradation of short-lived 
proteins in isolated hepatocytes. Hepatocytes labeled as 
described in section 2 were washed and incubated in the absence 
(0) or presence of 10 (A), 50 (0) and 100 (0) fig/ml R123. 
Each point is the mean of 4 separate experiments with 
duplicated samples. Bars represent standard errors. 
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Fig.2. ATP content in control and R123-treated hepatocytes. 
Hepatocytes were incubated in the absence (0) or presence of 
10 (A), 50 (0) or 100 (~)pg/ml R123 as described in section 2. 
Data are expressed as percentages of the ATP content at time 
zero. The average ATP content of control cells, in three 
separate experiments, was 4.3 nmol/mg protein. Each point is 
the mean of 4 separate experiments with duplicated samples. 
Bars represent standard errors. 
teins are degraded via the lysosomal pathway [23]. 
To clarify which pathway (i.e. lysosomal or non- 
lysosomal) of short-lived proteins in hepatocytes is 
inhibited by R123, we used leupeptin and NH&l, 
which suppress almost all lysosomal degradation in 
hepatocytes [23] (table 1). The inhibitory effects of 
R123 and leupeptin and NH&l were not additive 
and it can therefore be concluded that R123 sup- 
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Fig.3. Relationship between inhibition of the degradation of 
short-lived proteins and cellular ATP content. The data were 
calculated from figs 1,2 for 60 min incubation. Both short-lived 
protein degradation and ATP content are referred as % of 
control. Each point corresponds to a different R123 
concentration. 
Table 1 
Effect of R123 and lysosomal inhibitors on the degradation of 
short-lived proteins in isolated hepatocytes 
Additions Protein Inhibition 
degradation (Q) 
(7s) 
None 17.0 * 1.4 0 
Leupeptin + NHdCl 8.2 + 0.5 50 
R123 6.0 + 0.3 65 
Leupeptin + NH&I1 + R123 5.4 + 0.4 68 
Hepatocytes were labelled as described in section 2 and 
incubated for 2 h with the indicated additions: leupeptin 
(0.25 mM) and ammonium chloride (10 mM) and/or R123 
(100 fig/ml). Values are means + SD from 3 different 
experiments 
presses most of the lysosomal degradation. 
Moreover, since R123 also inhibited -35% of the 
degradation not affected by leupeptin and NH4C1, 
it appears that R123 also affects non-lysosomal 
degradation of short-lived proteins. 
In conclusion, it appears that in hepatocytes 
there are at least three different mechanisms 
operating in the degradation of short-lived pro- 
teins: a lysosomal mechanism (which requires 
ATP, as shown in [20], but which is different, in 
terms of quantitative requirements for ATP, from 
those operating in the degradation of long-lived 
proteins) and two non-lysosomal mechanisms, one 
requiring and the other not requiring ATP. These 
two non-lysosomal mechanisms of protein 
degradation have already been proposed in grow- 
ing fibroblasts [21]. Further, it has been reported 
that the lysosomal mechanisms in the degradation 
of short-lived proteins in hepatocytes (which could 
represent crinophagy or microautophagy) are not 
necessarily identical to those involved in the 
degradation of long-lived proteins (which could 
represent mainly macroautophagy) [23]. 
At any rate, since R123, in contrast to other 
metabolic inhibitors which affect many cellular 
functions, selectively affects mitochondrial pro- 
cesses [15-181, it provides an excellent ool for in- 
vestigating the relationship between energy needs 
and protein degradation under a variety of condi- 
tions. Finally, our results showing depletion of 
ATP content in normal hepatocytes uggest cau- 
tion in the clinical use of R123 in carcinoma 
chemotherapy [25]. 
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